News & Analysis on Clinical Trial Services & Contract Research And Development
UK encapsulation specialist BioProgress has signed a license option deal for a liquid fill technology with the consumer healthcare division of US drug major Wyeth. If taken to fruition, the agreement would mark the company's second partnership in the...
Hospira, the hospital products company spun out of Abbott Laboratories earlier this year, has acquired a manufacturing facility that will help it grow its pharmaceutical injectable and outsourcing business.
Researchers have isolated a protein that appears to be behind the curious phenomenon that severe dietary restruction can extend the lifespan of some organisms. The protein is thought to control whether a mammal stores fat or sheds it, writes Wai Lang...
3M will no longer manufacture triflic acid and is closing down its electrochemical fluorination process at the company's Cottage Grove, site in Illinois, US.
Despite advances made in sustained delivery drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have only a narrow absorption window in the upper part of the...
The annual US Biotechnology Industry Association event started this weekend in San Francisco with the usual showcase of new biopharmaceuticals and other technologies. But aside from supplying the drugs of the future, the biotechnology industry is also...
This week has seen three companies put forward different solutions to the topical issue of improving the yield of proteins and nucleic acids made by biomanufacturing technologies.